Severe TSH elevation and pituitary enlargement after changing thyroid replacement to compounded T4/T3 therapy

Journal of Investigative Medicine High Impact Case Reports

Volumn 4, Issue 3, 2016, Pages

  Pappy, Adlai L ^a   Oyesiku, Nelson ^a   Ioachimescu, Adriana ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

Compounded T4 T3; Hypothyroidism; Levothyroxine; Pituitary enlargement; Pituitary hyperplasia

Indexed keywords

CREATINE KINASE; LIOTHYRONINE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; BLOATING; CASE REPORT; CONSTIPATION; FATIGUE; HEADACHE; HORMONE SUBSTITUTION; HUMAN; HYPOPHYSIS DISEASE; HYPOTHYROIDISM; INSOMNIA; MALE; MIDDLE AGED; MUSCLE CRAMP; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SIDE EFFECT; SLEEP DISORDER; VISUAL DISORDER; WEIGHT GAIN;

EID: 85050580620     PISSN: None     EISSN: 23247096     Source Type: Journal    
DOI: 10.1177/2324709616661834     Document Type: Article

References (34)

1. Jonklaas J, Davidson B, Bhagat S, Soldin SJ. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy. JAMA. 2008;299:769-777. doi:10.1001/jama.299.7.769.
2. Gullo D, Latina A, Frasca F, Le Moli R, Pellegriti G, Vigneri R. Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients. PLoS One. 2011;6(8):e22552. doi:10.1371/journal.pone.0022552.
3. Alevizaki M, Mantzou E, Cimponeriu AT, Alevizaki CC, Koutras DA. TSH may not be a good marker for adequate thyroid hormone replacement therapy. Wien Klin Wochenschr. 2005;117:636-640. doi:10.1007/s00508-005-0421-0.
4. Woeber KA. Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations. J Endocrinol Invest. 2002;25:106-109. doi:10.1007/BF03343972.
5. Pepper GM, Casanova-Romero PY. Conversion to armour thyroid from levothyroxine improved patient satisfaction in the treatment of hypothyroidism. J Endocrinol Diabetes Obes. 2014;2(3):1055.
6. Bains A, Brosseau A, Harrison D. Iatrogenic thyrotoxicosis secondary to compounded liothyronine. Can J Hosp Pharm. 2015;68:57-59.
7. Jha S, Waghdhare S, Reddi R, Bhattacharya P. Thyroid storm due to inappropriate administration of a compounded thyroid hormone preparation successfully treated with plasmapheresis. Thyroid. 2012;22:1283-1286. doi:10.1089/thy.2011.0353.
8. Food and Drug Administration. Compounding and the FDA: questions and answers. http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/PharmacyCompounding/ucm339764.htm. Accessed July 19, 2016.
9. Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014;24:1670-1751. doi:10.1089/thy.2014.0028.
10. Garber JR, Cobin RH, Garber JR, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18: 988-1028.
11. Appelhof BC, Fliers E, Wekking EM, et al. Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: A double-blind, randomized, controlled clinical trial. J Clin Endocrinol Metab. 2005;90:2666-2674. doi:10.1210/jc.2004-2111.
12. Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med. 1999;340:424-429. doi:10.1056/NEJM199902113400603.
13. Bunevicius R, Jakubonien N, Jurkevicius R, Cernicat J, Lasas L, Prange AJ. Thyroxine vs thyroxine plus triiodothyronine in treatment of hypothyroidism after thyroidectomy for Graves’ disease. Endocrine. 2002;18:129-133. doi:10.1385/ENDO:18:2:129.
14. Clyde PW, Harari AE, Getka EJ, Shakir KMM. Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial. JAMA. 2003;290:2952-2958. doi:10.1001/jama.290.22.2952.
15. Escobar-Morreale HF, Botella-Carretero JI, Gómez-Bueno M, Galán JM, Barrios V, Sancho J. Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone. Ann Intern Med. 2005;142:412-424
16. Fadeyev VV, Morgunova TB, Melnichenko GA, Dedov II. Combined therapy with L-thyroxine and L-triiodothyronine compared to L-thyroxine alone in the treatment of primary hypothyroidism. Hormones (Athens). 2010;9:245-252.
17. Nygaard B, Jensen EW, Kvetny J, Jarlov A, Faber J. Effect of combination therapy with thyroxine (T4) and 3,5,3′-triiodothyronine versus T4 monotherapy in patients with hypothyroidism, a double-blind, randomised cross-over study. Eur J Endocrinol. 2009;161:895-902. doi:10.1530/EJE-09-0542.
18. Rodriguez T, Lavis VR, Meininger JC, Kapadia AS, Stafford LF. Substitution of liothyronine at a 1:5 ratio for a portion of levothyroxine: effect on fatigue, symptoms of depression, and working memory versus treatment with levothyroxine alone. Endocr Pract. 2005;11:223-233. doi:10.4158/EP.11.4.223.
19. Saravanan P, Simmons DJ, Greenwood R, Peters TJ, Dayan CM. Partial substitution of thyroxine (T4) with tri-iodothyronine in patients on T4 replacement therapy: results of a large community-based randomized controlled trial. J Clin Endocrinol Metab. 2005;90:805-812. doi:10.1210/jc.2004-1672.
20. Sawka AM, Gerstein HC, Marriott MJ, MacQueen GM, Joffe RT. Does a combination regimen of thyroxine (T4) and 3,5,3′-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial. J Clin Endocrinol Metab. 2003;88:4551-4555. doi:10.1210/jc.2003-030139.
21. Siegmund W, Spieker K, Weike AI, et al. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14:1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism. Clin Endocrinol (Oxf). 2004;60:750-757. doi:10.1111/j.1365-2265.2004.02050.x.
22. Valizadeh M, Seyyed-Majidi MR, Hajibeigloo H, Momtazi S, Musavinasab N, Hayatbakhsh MR. Efficacy of combined levothyroxine and liothyronine as compared with levothyroxine monotherapy in primary hypothyroidism: a randomized controlled trial. Endocr Res. 2009;34:80-89. doi:10.1080/07435800903156340.
23. Walsh JP, Shiels L, Lim EM, et al. Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism. J Clin Endocrinol Metab. 2003;88:4543-4550. doi:10.1210/jc.2003-030249.
24. Escobar-Morreale HF, Botella-Carretero JI, Escobar del Rey F, Morreale de Escobar G. Review: Treatment of hypothyroidism with combinations of levothyroxine plus liothyronine. J Clin Endocrinol Metab. 2005;90:4946-4954. doi:10.1210/jc.2005-0184.
25. Ma C, Xie J, Huang X, et al. Thyroxine alone or thyroxine plus triiodothyronine replacement therapy for hypothyroidism. Nucl Med Commun. 2009;30:586-593. doi:10.1097/MNM.0b013e32832c79e0.
26. Joffe RT, Brimacombe M, Levitt AJ, Stagnaro-Green A. Treatment of clinical hypothyroidism with thyroxine and triiodothyronine: a literature review and metaanalysis. Psychosomatics. 2007;48:379-384. doi:10.1176/appi.psy.48.5.379.
27. Grozinsky-Glasberg S, Fraser A, Nahshoni E, Weizman A, Leibovici L. Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. 2006;91:2592-2599. doi:10.1210/jc.2006-0448.
28. Snyder S, Listecki RE. Bioidentical thyroid replacement therapy in practice: delivering a physiologic T4:T3 ratio for improved patient outcomes with the Listecki-Snyder protocol. Int J Pharm Compd. 2012;16:376-380.
29. Niepce B. Traité du goître et du crétinisme : suivi de la statistique des goîtreux et des crétins dans le bassin de l’Isère en Savoie, dans les départements de l’Isère, des Hautes-Alpes et des Basses-Alpes. Paris, France: J-B Baillière; 1851.
30. Eiland L, Oyesiku NM, Ritchie JC, Isaacs S, Ioachimescu AG. Pathogenesis of marked pituitary enlargement and increased serum thyroid-stimulating hormone in primary hypothyroidism. Thyroid. 2012;22:101-102. doi:10.1089/thy.2011.0237.
31. Valenta LJ, Tamkin J, Sostrin R, Elias AN, Eisenberg H. Regression of a pituitary adenoma following levothyroxine therapy of primary hypothyroidism. Fertil Steril. 1983;40:389-392.
32. Pereira Filho Ade A, Gobbato PL, Pereira Filho Gde A, Silva SB, Kraemer JL. Intracranial intrasellar kissing carotid arteries: case report. Arq Neuropsiquiatr. 2007;65(2A):355-357.
33. Sahin M, Dilli A, Karbek B, et al. Unusual cause of primary amenorrhea due to kissing internal carotid arteries. Pituitary. 2012;15:258-259. doi:10.1007/s11102-012-0393-9.
34. Kim JM, Song EJ, Seo JS, Nam EJ, Kang YM. Polymyositislike syndrome caused by hypothyroidism, presenting as camptocormia. Rheumatol Int. 2009;29:339-342. doi:10.1007/s00296-008-0679-4